SATURDAY, SEPTEMBER 6, 2025

PROGRAM TOPICS

BREAST CANCER

Education – Learning from the Best
08.15 am to 08.45 am
High-Risk Patients: Surgical Perspectives
Safety of Lipofilling in Breast Cancer Surgery
Surgical Strategy for Young Breast Cancer Patients
Novartis Satellite Symposium
08.45 am to 09.30 am
Update on Systemic Treatment in Breast Cancer:
What is Proven, What is Coming Next?
10.00 am to 11.40 am
Triple-Negative Breast Cancer – From Early to Metastatic Disease
HER2/neu-Positive Disease – From Early to Metastatic Disease
HR-Positive Early Breast Cancer – Who Needs Chemotherapy?
HR-Positive Metastatic Breast Cancer – Which Drugs and When?
Live Discussion and Live Chat
Daiichi Sankyo Scientific Symposium
11.40 am to 12.40 pm
Local Therapy I – Axilla Surgery
01.30 pm to 02.45 pm
Clinically Negative Axilla: Primary or After Neoadjuvant Systemic Therapy – What is Standard and What Questions Remain Unanswered?
After SOUND and INSEMA Trials – Where we are? No Surgery or No Radiotherapy?
Clinically Positive Axilla: Who Needs Axillary Clearance? Is it More Complicated than Positive or Negative?
Live Discussion and Live Chat
Local Therapy II
02.45 pm to 03.55 pm
Residual Nodal Disease: Real-World Studies Help when Results from Randomized Trials are Pending
Surgery of the Primary Tumour at Stage IV Disease – Where we are?
Local Therapy at Oligoprogression: Surgery? Radiotherapy? Both? – Or Only Change of Systemic Therapy?
Live Discussion and Live Chat
Status: April 2025; program topics and times may be subject to change